|
|
 |
|
Viewing report
|
|
|
|
Global Pharmaceutical Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Buyer Spend and Procurement Strategies
iCD Research, June 2011, Pages: 124
Synopsis
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how pharmaceutical companies’ procurement expenditure, business strategies and practices are set to change in 2011–2012. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how pharmaceutical companies’ procurement expenditure, business strategies and practices are set to change in 2011–2012. This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.
Scope
The opinions and forward looking statements of 764 industry executives have been captured in our in-depth survey, of which 41% represent Director and C-level respondents
The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations
The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East
This report covers data and analysis on buyer expenditure, procurement and industry developments
Key topics covered include packaging buyer expenditure activity, procurement behaviors and strategies, threats and opportunities for the pharmaceutical industry, economic outlook and business confidence.
In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
The report examines current practices and provides future expectations over the next 12-24 months
The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results
Reasons To Buy
Drive revenues by understanding future product investment areas and growth regions
Formulate effective sales and marketing strategies by identifying how buyer budgets are changing and direction of spend in the future
Better promote your business by aligning your capabilities and business practices with your customer’s changing needs
Secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers
Predict how the industry will grow, consolidate and where it will stagnate
Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers
Key Highlights
China, India and Brazil are predicted to be the fastest growing regions among developing countries for the pharmaceutical industry. An aging population, growth of chronic diseases, expanding healthcare insurance coverage, urbanization and increasing investment in rural healthcare services are major drivers for the growth.
The majority of the pharmaceutical companies will be increasing procurement spend over the next 12 months. The average size of the annual procurement budgets of pharmaceutical manufacturing companies, CROs and CMOs is US$110 million.
Overall, 44% of respondents from pharmaceutical industry buyers agree that in order to maintain and win their business, suppliers will have to engage in partnerships to optimize working capital and reduce costs.
|
|
|
|
